John Burnier
32Patents
18h-index
29Co-inventors
81Inventor score
Filing activity: Jun 23, 1986 → Aug 12, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8168655B2 | Compositions and methods for treatment of eye disorders | Physics | 78 | Active |
| US5846932A | Receptor specific atrial natriuretic peptides | Human Necessities | 52 | Expired |
| US5665704A | Receptor specific atrial natriuretic peptides | Human Necessities | 45 | Expired |
| US5493007A | Platelet aggregation inhibitors having high specificity for GPIIBIIIA | Emerging Cross-Sectional Technologies | 35 | Expired |
| US5118791A | Biologically active polypeptides based on transforming growth factor-.beta. | Human Necessities | 34 | Expired |
| US8080562B2 | Crystalline pharmaceutical and methods of preparation and use thereof | Human Necessities | 32 | Active |
| US8367701B2 | Crystalline pharmaceutical and methods of preparation and use thereof | Human Necessities | 29 | Active |
| US5061786A | Biologically active polypeptides based on transforming growth factor-.beta. | Emerging Cross-Sectional Technologies | 28 | Expired |
| US5798337A | Low molecular weight peptidomimetic growth hormone secretagogues | Human Necessities | 27 | Expired |
| US5403737A | Serine protease variants having peptide ligase activity | Chemistry; Metallurgy | 26 | Expired |
| US6525022B1 | Receptor specific atrial natriuretic peptides | Human Necessities | 26 | Expired |
| US5384309A | Cyclized peptides and their use as platelet aggregation inhibitors | Chemistry; Metallurgy | 24 | Expired |
| US8927574B2 | Crystalline pharmaceutical and methods of preparation and use thereof | Chemistry; Metallurgy | 22 | Active |
| US8592450B2 | Compositions and methods for treatment of eye disorders | Physics | 21 | Active |
| US9353088B2 | Crystalline pharmaceutical and methods of preparation and use thereof | Chemistry; Metallurgy | 21 | Active |
| US5629173A | Methods of use of serine protease variants having peptide ligase activity | Chemistry; Metallurgy | 20 | Expired |
| US9447077B2 | Crystalline pharmaceutical and methods of preparation and use thereof | Human Necessities | 20 | Active |
| US4835251A | Method of chain combination | Emerging Cross-Sectional Technologies | 18 | Expired |
| US9890141B2 | Crystalline pharmaceutical and methods of preparation and use thereof | Chemistry; Metallurgy | 17 | Active |
| US5736512A | Serine protease variants having peptide ligase activity | Chemistry; Metallurgy | 9 | Expired |
| US7538252B2 | Drug design for tubulin inhibitors, compositions, and methods of treatment thereof | Physics | 8 | Active |
| US8378105B2 | Crystalline pharmaceutical and methods of preparation and use thereof | Chemistry; Metallurgy | 5 | Active |
| US6034216A | Low molecular weight peptidomimetic growth hormone secretagogues | Human Necessities | 3 | Expired |
| US8143447B2 | Treatment of cancer | Chemistry; Metallurgy | 3 | Active |
| US9045457B2 | Compositions and methods for treatment | Physics | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.